logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12129218 B1

PDFFull Text
Date of Patent:
Oct. 29, 2024

Filed:

Jul. 24, 2019

Autotac chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same

Applicant:

Autotac Inc., Seoul, KR;

Inventors:

Yong Tae Kwon, Seoul, KR;

Chang Hoon Ji, Seoul, KR;

Srinivasrao Ganipisetti, Seoul, KR;

Hee Yeon Kim, Seoul, KR;

Su Ran Mun, Seoul, KR;

Chan Hoon Jung, Seoul, KR;

Eui Jung Jung, Seoul, KR;

Ki Woon Sung, Seoul, KR;

Assignee:

AUTOTAC INC., Seoul, KR;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Karl J Puttlitz

Int. Cl.
CPC ...
A61K 39/395 (2006.01); A23L 33/10 (2016.01); A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61K 31/138 (2006.01); A61K 31/166 (2006.01); A61K 31/192 (2006.01); A61K 31/277 (2006.01); A61K 31/336 (2006.01); A61K 31/355 (2006.01); A61K 31/4015 (2006.01); A61K 31/4155 (2006.01); A61K 31/4184 (2006.01); A61K 31/421 (2006.01); A61K 31/428 (2006.01); A61K 31/4535 (2006.01); A61K 31/4709 (2006.01); A61K 31/4745 (2006.01); A61K 31/496 (2006.01); A61K 31/50 (2006.01); A61K 31/5025 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); A61K 31/5415 (2006.01); A61K 31/551 (2006.01); A61K 31/565 (2006.01); A61K 47/54 (2017.01); A61K 47/55 (2017.01); A61K 47/68 (2017.01); A61P 25/28 (2006.01); C07C 43/23 (2006.01); C07C 47/575 (2006.01); C07C 217/58 (2006.01); C07C 235/06 (2006.01); C07C 237/06 (2006.01); C07C 275/24 (2006.01); C07C 279/12 (2006.01); C07D 303/18 (2006.01);
U.S. Cl.
CPC ...
C07C 217/58 (2013.01); A23L 33/10 (2016.08); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/138 (2013.01); A61K 31/166 (2013.01); A61K 31/192 (2013.01); A61K 31/277 (2013.01); A61K 31/336 (2013.01); A61K 31/355 (2013.01); A61K 31/4015 (2013.01); A61K 31/4155 (2013.01); A61K 31/4184 (2013.01); A61K 31/421 (2013.01); A61K 31/428 (2013.01); A61K 31/4535 (2013.01); A61K 31/4709 (2013.01); A61K 31/4745 (2013.01); A61K 31/496 (2013.01); A61K 31/50 (2013.01); A61K 31/5025 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 31/5415 (2013.01); A61K 31/551 (2013.01); A61K 31/565 (2013.01); A61K 39/3955 (2013.01); A61K 47/54 (2017.08); A61K 47/55 (2017.08); A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61P 25/28 (2018.01); C07C 43/23 (2013.01); C07C 47/575 (2013.01); C07C 235/06 (2013.01); C07C 237/06 (2013.01); C07C 275/24 (2013.01); C07C 279/12 (2013.01); C07D 303/18 (2013.01); C07B 2200/07 (2013.01);
Abstract

The present invention relates to a novel AUTOTAC chimeric compound in which a new p62 ligand and a target-binding ligand are connected by a linker, a stereoisomer, hydrate, solvate or prodrug thereof, and a pharmaceutical or food composition for the prevention or treatment of diseases by degrading the target protein including the same as an active ingredient. They can target specific proteins to adjust their concentrations, and can also deliver drugs and other small molecule compounds to lysosomes. The AUTOTAC chimeric compound according to the present invention can be usefully used as a pharmaceutical composition for the prevention, amelioration or treatment of various diseases by selectively eliminating specific proteins.

Find Patent Forward Citations

Loading…